Biomedical Informatics Market Leader BioFortis wins another award for its Labmatrix(TM) platform being used by leading pharmaceutical and institutional clients worldwide for translational research, biomarker discovery, biobanking, and clinical research
COLUMBIA, Md., March 5 /PRNewswire/ -- BioFortis, Inc., the leading provider of biomedical informatics solutions used by pharmaceutical and institutional clients, today announced it has won the 2009 Molecular Medicine Tri-Conference "Best Product Award" for its leading Labmatrix(TM) platform. The award is given to the best peer-reviewed solution at the annual conference.
The Best Product Award honored companies that launched the best products at the 2009 Molecular Medicine Tri-Conference. Approximately 2600 attendees of the conference were invited to vote on the contestants' products and the winners were announced at a special ceremony.
Labmatrix(TM) was designed as a solution to enable a comprehensive "bench-to-bedside" approach to the study of human diseases, while permitting collaboration in a secure environment that facilitates regulatory compliance. Labmatrix(TM) provides a clear competitive advantage for organizations that must keep pace in an era of new, high-throughput technologies utilized in discovery programs focused on next-generation therapeutics. BioFortis is the leader in information management for translational research, biomarker discovery, biobanking and clinical research, supporting multiple pharmaceutical clients and research institutions in their mission of speeding drug discovery and driving personalized medicine into practice.
"We are thrilled to win this award," said Jian Wang, BioFortis CEO, "especially considering it is an award voted on by researchers directly. This validates our mission to create data management and exploration tools that are so easy scientists can use effectively from day one. This award reaffirms our leadership position in providing informatics solutions for translational and biomarker researchers."
BioFortis is a leading provider of biomedical informatics solutions. Our lead product, Labmatrix(TM), addresses research needs of the post-genomic era within several key application areas including translational research, biobanking, biomarker discovery and clinical research. Labmatrix(TM) is a web-based software application for the management and exploration of clinical, specimen and molecular assay data. With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix(TM) is being used by customers in the biopharmaceutical industry, academia and government research institutions.
BioFortis and Labmatrix(TM) are registered trademarks of BioFortis, Inc.
|SOURCE BioFortis, Inc.|
Copyright©2009 PR Newswire.
All rights reserved